Is OS up or down today?
OS is up 0.48% today, last at 314.99. This stock moved +0.48% versus the prior close.
OS · OS
OS (OS) is trading at 314.99, up 0.48% on the session. OS carries a 14-day RSI of 52, and trades below its 50-day average. Over the past month it is up 0.21%.
Leading the coverage: “OS Q4 2025 Earnings: EPS of $0.12 Tops Estimate by Roughly 137% - Revenue Beat Analysis - https://www.siam.in/” (Google News Earnings, 15d ago). OS is +1.26% since story.
OS trades on a trailing P/E of 41.5 and is running 0.46% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
OS is up 0.48% today, last at 314.99. This stock moved +0.48% versus the prior close.
Leading the coverage: “OS Q4 2025 Earnings: EPS of $0.12 Tops Estimate by Roughly 137% - Revenue Beat Analysis - https://www.siam.in/” (Google News Earnings, 15d ago). OS is +1.26% since story. Dominant story: 【Chugai Pharmaceutical FY2026 Q3 Earnings Call】Japan's Chugai Pharmaceutical Posts Q3 Revenue of ¥1.0681 Trillion, Up 17.2%, on Track to Beat Full-Year Guidance — Divarasib Shows PFS and OS Superiority Over First-Generation KRAS Inhibitors - finance.biggo.com (1 source, bullish) RSI is 52 — neutral Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Apr 2026 – Oct 2026 (181 days) · Drag or scroll left for earlier dates
【Chugai Pharmaceutical FY2026 Q3 Earnings Call】Japan's Chugai Pharmaceutical Posts Q3 Revenue of ¥1.0681 Trillion, Up 17.2%, on Track to Beat Full-Year Guidance — Divarasib Shows PFS and OS Superiority Over First-Generation KRAS Inhibitors - finance.biggo.com
Sac-TMT Improves PFS and OS, Is Under FDA Priority Review in Previously Treated Endometrial Cancer - OncLive
Could Oral Vitamin C Confer OS Benefit in CCUS and Lower-Risk MDS? - CancerNetwork
OS Q4 2025 Earnings: EPS of $0.12 Tops Estimate by Roughly 137% - Revenue Beat Analysis - https://www.siam.in/
Officina Stellare (BIT:OS) Stock Grapples With Strong Sales And Fresh Loss - Simply Wall Street